Federal Health experts met Thursday, December 8, 2011, to discuss the warning labels administered by Bayer's drug Yaz. A close vote, 15-11 experts agree that the benefits of birth control pills containing drospirenone not outweigh the risks, especially when there are alternative birth control pills out there with the same benefits and not the risks. However, the FDA experts voted 21-5 that Bayer should update their warning labels, based on the evidence in recent studies, which suggest increased risk of blood clots.

The panel of experts spent over nine hours arguing the data presented on the blood clot risks associated with birth controls containing drospirenone. The panel disagreed on much of the quality of data but agreed that it showed enough evidence to make necessary changes to the labeling, including the potentially fatal nature of blood clots.

Yas and Yasmin, unlike other birth control pills, use a synthetic hormone called drospirenone, which mimics the natural female hormone progesterone. Drospirenone has been linked to many dangerous health issues like blood clots, stroke, heart attack, gallbladder disease, organ failure, cancer, and even sudden death. If you or someone you know have been injured by Yaz or Yasmin, please contact Parilman Law & Associates.